A Phase I Trial of Anti-GD2 T-cells (1RG-CART)

Clinical trial NCT02761915 · COMPLETED

Trial details

NCT number: NCT02761915
Sponsor: Cancer Research UK
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed or Refractory Neuroblastoma

Start date: 2016-02-29
Primary completion: 2020-12-16
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.